MBNL2 enhances cisplatin resistance by regulating apoptosis in ovarian cancer cells.

Although the P-values were marginally significant or not significant, the mRNA expression levels of MBNL2 were generally lower in responders, those sensitive to treatment, or those without disease recurrence, across five public datasets ( Fig. 4A ).

also in 26,082 other papers